VA-CTA
13.6.2019 17:05:12 CEST | Business Wire | Press release
CES Asia 2019 concluded today, shining a spotlight on the transformative technologies that will revolutionize the Asian marketplace and improve lives around the world. With its largest exhibit floor to date – an over 14% increase from 2018 – CES Asia 2019 cemented itself as Asia’s most influential tech event and the place to experience this rapid pace of innovation hitting the Asian market.
“At CES Asia 2019 we saw a convergence of industries,” said Gary Shapiro, president and CEO, CTA. “From global tech leaders to fashion, travel and tourism visionaries, it’s clear that tech innovation for the Asian marketplace is accelerating at a lightning speed and spurring new partnerships and growth on a global scale.”
A curated show that is now in its fifth year, CES Asia 2019 featured more than 550 exhibiting companies across the entire tech ecosystem, Including 115 startups from seven countries. Japan, Korea and the U.S. more than doubled their exhibitor presence year-over-year at CES Asia 2019. There was also a strong representation of over 24 Swiss companies at the show.
“CES Asia 2019 has been very successful for Nu Skin Enterprises. This is our first effort to present our automated controlled environment agriculture technology to the world,” said Brent Petersen, marketing and communications, Nu Skin Enterprises. “Asia is a very important market for Nu Skin, so based on the tremendous success and interest in our products during the show we’ve decided to double our exhibition space for CES Asia 2020.”
The CES Asia Conference Program featured three full days of sessions with more than 150 executives from global brands including APTIV, IBM China, Mobvoi, Deloitte, WeRide and SAP. Sessions covered a wide range of topics, including smart mobility, machine learning, digital health, blockchain and sustainability. View the full conference schedule here.
“BoCo is changing the future,” said Dr. Zhou Xinhong, CEO, BoCo. “CES Asia provided us the platform to showcase our mission – to use advanced bone conduction technology to build a better relationship between people and sound.”
CES Asia Keynotes (click here to see a recap of day one keynotes )
Industry visionaries took to the CES Asia keynote stage to discuss the future of innovation and trends that will redefine the industry. Dr. Chang Huang, co-founder and VP of Horizon Robotics, unveiled Horizon Robotics’ advancements in edge computing and the company’s strategy for future AI applications. Dr. Huang introduced joint optimization and flexible features of the Horizon algorithm, chip and compiler.
During his keynote address on June 12, Mr. Nobu Ide, president and CEO of Wacom, unveiled the company’s vision for the future of digital ink. Ide showcased innovative solutions in Extended Reality (XR) to enable XR drawing in open and 3D environments. He also highlighted the importance of partnerships to empower designers with creative freedom including several they had with Gravity Sketch, Magic Leap, Staedtler, BIC, Leapie and iFLYTEK.
Michelle Toh, multiplatform editor at CNN, moderated a keynote panel focused on Tech Innovation in Travel and Tourism. Wong Hong, president of Greater China and Singapore at Delta Air Lines, stressed the responsibility to envision future technology revolutions in order to keep up with customers’ growing needs. Helen Huang, president of Greater China at MSC Cruises, discussed how IoT and AI enable broad connectivity and personalization opportunities, allowing companies to optimize services and customer experiences.
CES Asia Conference Sessions
Yesterday’s Tech4Good panel addressed the ability of technology to solve global challenges. The panel was presented by Citypreneurs, a UN-backed platform for impact-driven innovation, and explored sustainable ventures and frontier technologies aimed to achieve sustainability through partnerships at the city level.
The Power of Diversity, Innovation and Sustainability panel, presented by Ladies Who Tech, showcased China’s emerging role as an innovation hub. The panel featured experts and visionaries who explored the power that the convergence of diversity, innovation and sustainability, has to make the world a better place.
CES Asia Exhibitor Announcements
Exhibitors unveiled products and announced partnerships during 22 media events throughout the show (click here to view day one announcements ). Major product announcements from exhibitor news conferences included:
- HiScene – Introduced AR smart glasses HiAR G200
- Ningbo Sogen Electronics Technology Co., Ltd. – Launched its latest BH03 bone conduction Bluetooth headphones with a wraparound titanium design to make them lighter and more comfortable to wear, giving consumers an extraordinary experience.
CES Asia Award Programs
CES Asia featured several awards programs honoring cutting-edge products and technologies. The Best of CES Asia Awards, presented by ZOL, recognized breakthrough innovation across product categories, including AI, vehicle tech and startups, with Hisense taking home the top prize with its 4K Laser Television 100L7. Click here to see the full list of winners .
CES Asia 2019 was strong across all measures with a preliminary analysis indicating more than 40,000 attendees, including more than 1,400 members of the global media. CES Asia is one of Asia’s fastest growing tech events, bringing together the entire tech ecosystem to build brands, forge partnerships and celebrate the best in consumer tech in Asia. For the latest news, photos, b-roll and more, visit CESAsia.com . CES Asia will return to Shanghai, June 10-12, 2020.
About CES Asia:
Owned and produced by the International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex Exhibition Co., Ltd (Shanghai Intex), CES Asia is the premier event for the consumer technology industry, showcasing the full breadth and depth of the innovation value-chain in the Asian marketplace. Key global businesses come to this event to grow and reinforce their brand by showcasing the latest products and technologies to consumer tech industry executives, foreign buyers and international media. Attendees have exclusive access to some of the largest brands from China and around the world, while celebrating the innovation that defines the consumer technology sector.
About International CES (Shanghai) Exhibition Co. Ltd. and CTA:
International CES (Shanghai) Exhibition Co. Ltd. is a wholly foreign-owned enterprise by the Consumer Technology Association (CTA), a trade association representing the $398 billion U.S. consumer technology industry, which supports more than 18 million U.S. jobs. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best-known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. CTA also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.
About Shanghai Intex:
Taken independent in July 2016, Shanghai Intex Exhibition (Co., Ltd.) was originally founded in 1995 as the pioneering exhibition organizing business of Intex Shanghai, the first joint venture venue management business in Shanghai. Shanghai Intex is jointly overseen by the China Council for the Promotion of International Trade (CCPIT) Shanghai and PNO Exhibitions, giving it the perfect combination of domestic and international resources. Over the last 20 years, Shanghai Intex has organized more than 100 tradeshows and over 1000 conferences, with a sum total show space in excess of 2 million square meters. Shanghai Intex runs a number of internationally renowned exhibitions covering the music industry, healthcare, lifestyle, advanced manufacturing, public transportation, floriculture, consumer electronics, technology and more.
UPCOMING EVENTS
-
CEO
Summit
June 23-26 – Prague, Czech Republic -
Technology
& Standards Fall Forum
September 23 – Los Angeles, CA -
CES
Unveiled in Paris
October 22 – Paris, France -
CES
Unveiled in Amsterdam
October – Amsterdam, Netherlands -
CES
2020
January 7-10, 2020 – Las Vegas, NV
View source version on businesswire.com: https://www.businesswire.com/news/home/20190613005502/en/
Contact:
Teresa Hsu 703-907-5259 thsu@CTA.tech
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
